Türkay Cansel, Yönem Ozlem, Arikan Osman, Baskin Esra
Department of Gastroenterology, Fatih University Internal Medicine, Ankara, Turkey.
Turk J Gastroenterol. 2004 Jun;15(2):73-6.
BACKGROUND/AIMS: Nitric oxide, a potent vasodilating agent, has been proposed to play a role in pathogenesis of ascites and hepatorenal syndrome. The aim of this study was to evaluate the interaction between the plasma nitric oxide, nitric oxide synthetase levels and renal functions in patients with different degrees of chronic liver disease.
The study population included 38 subjects: 14 patients with chronic hepatitis, 11 with preascitic cirrhosis and 13 with ascitic cirrhosis. Nitric oxide and nitric oxide synthetase were determined by colorometric assay. We calculated glomerular filtration rate and fractional sodium excretion.
Nitric oxide levels in groups were as follows: 79.28+/-24.86, 99.03+/-21.31, 197.05+/-49.61 microm, respectively. Nitric oxide synthetase levels were 2.64+/-0.56, 3.64+/-0.89, 7.75+/-2.46 micromol/L/sec, respectively. Nitric oxide and nitric oxide synthetase levels in the ascitic cirrhotic group were significantly higher than in the others (p<0.05). When glomerular filtration rates were compared, the only significant difference was determined between the groups with chronic hepatitis and ascitic cirrhosis (92.31+/-25.21, 48.46+/-16.45, p<0.05). Fractional sodium excretion was significantly increased in the ascitic cirrhotic group (4.42+/-2.76, p<0.05).
Nitric oxide and nitric oxide synthetase increased with progression of liver disease, especially in ascitic cirrhosis. We also showed that this increase negatively affects the renal tubular and glomerular functions.
背景/目的:一氧化氮是一种强效血管舒张剂,有人提出它在腹水和肝肾综合征的发病机制中起作用。本研究的目的是评估不同程度慢性肝病患者血浆一氧化氮、一氧化氮合酶水平与肾功能之间的相互作用。
研究人群包括38名受试者:14例慢性肝炎患者、11例腹水前期肝硬化患者和13例腹水肝硬化患者。采用比色法测定一氧化氮和一氧化氮合酶。我们计算了肾小球滤过率和钠排泄分数。
各组一氧化氮水平分别为:79.28±24.86、99.03±21.31、197.05±49.61微摩尔。一氧化氮合酶水平分别为2.64±0.56、3.64±0.89、7.75±2.46微摩尔/升/秒。腹水肝硬化组的一氧化氮和一氧化氮合酶水平显著高于其他组(p<0.05)。比较肾小球滤过率时,仅在慢性肝炎组和腹水肝硬化组之间发现显著差异(92.31±25.21、48.46±16.45,p<0.05)。腹水肝硬化组的钠排泄分数显著增加(4.42±2.76,p<0.05)。
一氧化氮和一氧化氮合酶随着肝病进展而增加,尤其是在腹水肝硬化中。我们还表明,这种增加对肾小管和肾小球功能有负面影响。